Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

Figure 1

Strong injection site reaction in patient 8 with positive immune response. (a) Representative picture showing a positive immune reaction at the local injection site (axillary region in patient 8; Grade 2 reaction categorized using CTCAE). (b) HLA-tetramer assay showing a very high level of URLC10-specific CD8-positive cells (44.6% of CD8-positive cells) observed after the 4-month vaccine treatment in patient 8.

Back to article page